Cargando…

The function of oxytocin: a potential biomarker for prostate cancer diagnosis and promoter of prostate cancer

PURPOSE: To measure the level of oxytocin in serum and prostate cancer (PCa) tissue and study its effect on the proliferation of PCa cells. RESULTS: Oxytocin level in serum was significantly increased in PCa patients compared with the no-carcinoma individuals. Additionally, the levels of oxytocin an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Huan, Fu, Shi, Chen, Qi, Gu, Meng, Zhou, Juan, Liu, Chong, Chen, Yanbo, Wang, Zhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458202/ https://www.ncbi.nlm.nih.gov/pubmed/28415720 http://dx.doi.org/10.18632/oncotarget.16107

Ejemplares similares

Fatty Acid Metabolism Reprogramming in Advanced Prostate Cancer
por: Xu, Huan, et al.
Publicado: (2021)

Diagnosis and treatment of gastrointestinal stromal tumor extending to prostate: A case report and literature review
por: Xu, Huan, et al.
Publicado: (2016)

Lack of adiponectin and adiponectin receptor 1 contributes to benign prostatic hyperplasia
por: Fu, Shi, et al.
Publicado: (2017)

Exploration of diagnostic biomarkers, microenvironment characteristics, and ursolic acid's therapeutic effect for benign prostate hyperplasia
por: Chen, Yanbo, et al.
Publicado: (2023)

Prostatic vascular damage induced by cigarette smoking as a risk factor for recovery after holmium laser enucleation of the prostate (HoLEP)
por: Xu, Huan, et al.
Publicado: (2016)

MAFG-AS1 is a prognostic biomarker and facilitates prostate cancer progression
por: Li, Peizhang, et al.
Publicado: (2022)

Smoking habits and benign prostatic hyperplasia: A systematic review and meta-analysis of observational studies
por: Xu, Huan, et al.
Publicado: (2016)

Adiponectin deficiency contributes to the development and progression of benign prostatic hyperplasia in obesity
por: Fu, Shi, et al.
Publicado: (2017)

Human Stromal Cells in the Peripheral Zone of the Prostate Promote Tumorigenesis of Prostatic Cancer Stem Cells through Up-regulation of C-Kit Expression
por: Peng, Yubing, et al.
Publicado: (2015)

SPOCK1 promotes tumor growth and metastasis in human prostate cancer
por: Chen, Qi, et al.
Publicado: (2016)

LncRNA DIO3OS regulated by TGF-β1 and resveratrol enhances epithelial mesenchymal transition of benign prostatic hyperplasia epithelial cells and proliferation of prostate stromal cells
por: Chen, Yanbo, et al.
Publicado: (2021)

Upregulation of Oxytocin Receptor in the Hyperplastic Prostate
por: Li, Zhuo, et al.
Publicado: (2018)

Biomarkers for Prostate Cancer: From Diagnosis to Treatment
por: Chen, Jia-Yan, et al.
Publicado: (2023)

Therapeutic Effects of 25-Hydroxyvitamin D on the Pathological Process of Benign Prostatic Hyperplasia: An In Vitro Evidence
por: Chen, Yanbo, et al.
Publicado: (2021)

Emerging biomarkers in the diagnosis of prostate cancer
por: Filella, Xavier, et al.
Publicado: (2018)

Modern biomarkers in prostate cancer diagnosis
por: Porzycki, Paweł, et al.
Publicado: (2020)

Biomarkers of Aggressive Prostate Cancer at Diagnosis
por: Boehm, Brock E., et al.
Publicado: (2023)

Value of serum free prostate-specific antigen density in the diagnosis of prostate cancer
por: Zou, Bing-Zi, et al.
Publicado: (2023)

The Identification of Potential Biomarkers and Biological Pathways in Prostate Cancer
por: Song, Zhengshuai, et al.
Publicado: (2019)

High-Fat Diet Induced Gut Microbiota Alterations Associating With Ghrelin/Jak2/Stat3 Up-Regulation to Promote Benign Prostatic Hyperplasia Development
por: Gu, Meng, et al.
Publicado: (2021)

Circulating miRNAs as Biomarkers for Prostate Cancer Diagnosis in Subjects with Benign Prostatic Hyperplasia
por: Jin, Wei, et al.
Publicado: (2020)

Serum Metabolic Profiling Identifies a Biomarker Panel for Improvement of Prostate Cancer Diagnosis
por: Xu, Huan, et al.
Publicado: (2021)

The potential of microRNAs as human prostate cancer biomarkers: A meta‐analysis of related studies
por: Song, Chun‐Jiao, et al.
Publicado: (2017)

Comprehensive Evaluation of TFF3 Promoter Hypomethylation and Molecular Biomarker Potential for Prostate Cancer Diagnosis and Prognosis
por: Nørgaard, Maibritt, et al.
Publicado: (2017)

SNAP25 is a potential prognostic biomarker for prostate cancer
por: Di, Longjiang, et al.
Publicado: (2022)

Potential Epigenetic Biomarkers for Prostate Cancer Screening
por: Bae, Jong-Myon
Publicado: (2018)

Liquid Biopsy Potential Biomarkers in Prostate Cancer
por: Neuhaus, Jochen, et al.
Publicado: (2018)

Multiparametric transrectal ultrasound for the diagnosis of peripheral zone prostate cancer and clinically significant prostate cancer: novel scoring systems
por: Chen, Tong, et al.
Publicado: (2022)

Research status and progress of the RNA or protein biomarkers for prostate cancer
por: Song, Chunjiao, et al.
Publicado: (2019)

Serum organic acid metabolites can be used as potential biomarkers to identify prostatitis, benign prostatic hyperplasia, and prostate cancer
por: He, Jinhua, et al.
Publicado: (2023)

miRNA-21 as High Potential Prostate Cancer Biomarker in Prostate Cancer Patients in Indonesia
por: Gunawan, Regina R, et al.
Publicado: (2023)

Potential Role of Seven Proteomics Tissue Biomarkers for Diagnosis and Prognosis of Prostate Cancer in Urine
por: Vujicic, Ivo, et al.
Publicado: (2022)

Promoter DNA methylation analysis reveals a combined diagnosis of CpG-based biomarker for prostate cancer
por: Tang, Yuanyuan, et al.
Publicado: (2017)

Evaluation of noise hazard during the holmium laser enucleation of prostate
por: Xu, Huan, et al.
Publicado: (2017)

Detection of Prostate Cancer Antigen 3 and Prostate Cancer Susceptibility Candidate in Non-DRE Urine Improves Diagnosis of Prostate Cancer in Chinese Population
por: Ye, Lie-Fu, et al.
Publicado: (2020)

The Diagnosis of Prostate Cancer
por: Schulz, Robert J.
Publicado: (2016)

Diagnosis of prostate cancer
por: Descotes, Jean-Luc
Publicado: (2019)

Fibromodulin Gene Variants (FMOD) as Potential Biomarkers for Prostate Cancer and Benign Prostatic Hyperplasia
por: Silva, Tamara, et al.
Publicado: (2022)

Circular RNA and its potential as prostate cancer biomarkers
por: Tucker, Dwayne, et al.
Publicado: (2020)

Identification of potential diagnostic and prognostic biomarkers for prostate cancer
por: Zhang, Qiang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uqoimuukb9nhocvf8tpn880kq0